vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-829Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWПНЕВМОКОККОВАЯ ИНФЕКЦИЯ И СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ЕЕ ПРОФИЛАКТИКИ — ЭПИДЕМИОЛОГИЧЕСКИЙ ОБЗОР СИТУАЦИИ В МИРЕ И В РОССИИPNEUMOCOCCAL INFECTION AND MODERN OPPORTUNITIES OF ITS PROPHYLAXIS — EPIDEMIOLOGICAL REVIEW OF SITUATION IN THE WORLD AND RUSSIAСидоренкоС.В.SidorenkoS.V.ЛобзинЮ.В.LobzinYu.V.ХаритС.М.KharitS.M.КоролеваИ.С.KorolevaI.S.ТаточенкоВ.К.TatochenkoV.K.НИИ детских инфекций, МоскваРоссияScientific Center of Children’s Infections, MoscowRussian FederationЦентральный НИИ эпидемиологии, МоскваРоссияCentral Scientific Center of Epidemiology, MoscowRussian FederationНаучный центр здоровья детей РАМН, МоскваРоссияScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowRussian Federation20101409201591Вопросы современной педиатрии6269Copyright © Сидоренко С., Лобзин Ю., Харит С., Королева И., Таточенко В., 20102010Сидоренко С., Лобзин Ю., Харит С., Королева И., Таточенко В.Sidorenko S., Lobzin Y., Kharit S., Koroleva I., Tatochenko V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/829

В обзоре проведен анализ данных о распространенности и микробном пейзаже пневмококковых инфекций в мире и в России, основанный как на результатах собственных исследований, так и на данных литературных источников. Оценены перспективы внедрения массовой вакцинопрофилактики пневмококковых инфекций у детей, начиная с возраста 2 мес, и прогноз ее возможной эффективности в зависимости от спектра серотипов, включенных в конъюгированные вакцины.

Ключевые слова: дети, пневмококковая инфекция, вакцинация, профилактика.(Вопросы современной педиатрии. 2010;9(1):62-69)

This review analyzes the data on prevalence and microbe picture of pneumococcal infections in the world and in Russia, based on the results of the proper studies and the literature data. The perspectives of introduction of mass vaccinoprophylaxis of pneumococcal infections in children starting from the age of 2 months old and prognosis of its effectiveness depending on serotype spectrum, included in conjugated vaccines, are estimated.

Key words: children, pneumococcal infection, vaccination, prophylaxis.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(1):62-69)

ReferencesPneumococcal conjugate vaccine for childhood immunization.WHO position paper. Wkly Epidemiol. Rec. 2007; 82 (12): 93–104.Pneumococcal conjugate vaccine for childhood immunization.WHO position paper. Wkly Epidemiol. Rec. 2007; 82 (12): 93–104.Eskola J., Takala A.K., Kela E. et al. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA. 1992; 268 (23): 3323–3327.Eskola J., Takala A.K., Kela E. et al. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA. 1992; 268 (23): 3323–3327.Harboe Z.B., Thomsen R.W., Ris A. et al. Pneumococcal Serotypes and Mortality following Invasive Pneumococcal Disease: A Population based Cohort Study. PLoS Med. 2009; 6 (5): 81.Harboe Z.B., Thomsen R.W., Ris A. et al. Pneumococcal Serotypes and Mortality following Invasive Pneumococcal Disease: A Population based Cohort Study. PLoS Med. 2009; 6 (5): 81.URL: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/spneu99.pdfURL: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/spneu99.pdfGranat S.M., Ollgren J., Herva E. et al. Epidemiological Evidence for Serotype-Independent Acquired Immunity to Pneumococcal Carriage. J. Infect Dis. 2009.Granat S.M., Ollgren J., Herva E. et al. Epidemiological Evidence for Serotype-Independent Acquired Immunity to Pneumococcal Carriage. J. Infect Dis. 2009.Regev–Yochay G., Raz M., Dagan R. et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin. Infect. Dis. 2004; 38 (5): 632–639.Regev–Yochay G., Raz M., Dagan R. et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin. Infect. Dis. 2004; 38 (5): 632–639.Syrogiannopoulos G.A., Grivea I.N., Davies T.A. et al. Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin. Infect. Dis. 2000; 31 (4): 887–893.Syrogiannopoulos G.A., Grivea I.N., Davies T.A. et al. Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin. Infect. Dis. 2000; 31 (4): 887–893.Nunes S., Sa–Leao R., Carrico J. et al. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J. Clin. Microbiol. 2005; 43 (3): 1285–1293.Nunes S., Sa–Leao R., Carrico J. et al. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J. Clin. Microbiol. 2005; 43 (3): 1285–1293.Alter S.J. Pneumococcal infections. Pediatr. Rev. 2009; 30 (5): 155–164.Alter S.J. Pneumococcal infections. Pediatr. Rev. 2009; 30 (5): 155–164.WHO. Pneumococcal vaccines. Weekly Epidemiol. Record. 2003; 4: 110–119.WHO. Pneumococcal vaccines. Weekly Epidemiol. Record. 2003; 4: 110–119.Williams B.G., Gouws E., Boschi–Pinto C. et al. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet. 2002; 2 (1): 25–32.Williams B.G., Gouws E., Boschi–Pinto C. et al. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet. 2002; 2 (1): 25–32.Vergison A., Tuerlinckx D., Verhaegen J. et al. Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough. Pediatrics. 2006; 118 (3): 801–809.Vergison A., Tuerlinckx D., Verhaegen J. et al. Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough. Pediatrics. 2006; 118 (3): 801–809.URL: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=646.URL: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=646.Levine В.S., Cherian T., Hajjeh R. et al. Progress and Future Challenges in Coordinated Surveillance and Detection of Pneumococcal and Hib Disease in Developing Countries. Clinical Infectious Diseases. 2009; 48 (2): 33–36.Levine В.S., Cherian T., Hajjeh R. et al. Progress and Future Challenges in Coordinated Surveillance and Detection of Pneumococcal and Hib Disease in Developing Countries. Clinical Infectious Diseases. 2009; 48 (2): 33–36.Amos B., Kisakye A., Makewa D. et al. Behind the Data: Establishing the Network for Surveillance of Pneumococcal Disease in the East African Region. Clinical Infectious Diseases. 2009; 48 (2): 162–171.Amos B., Kisakye A., Makewa D. et al. Behind the Data: Establishing the Network for Surveillance of Pneumococcal Disease in the East African Region. Clinical Infectious Diseases. 2009; 48 (2): 162–171.Anh В.D., Kilgore В.E., Slack В.E. et al. Surveillance of Pneumococcal‐Associated Disease among Hospitalized Children in Khanh Hoa Province, Vietnam. Clinical Infectious Diseases. 2009; 48 (2): 57–64.Anh В.D., Kilgore В.E., Slack В.E. et al. Surveillance of Pneumococcal‐Associated Disease among Hospitalized Children in Khanh Hoa Province, Vietnam. Clinical Infectious Diseases. 2009; 48 (2): 57–64.Arifeen В.E., Saha В.K., Rahman S. et al. Invasive Pneumococcal Disease among Children in Rural Bangladesh: Results from a Population Based Surveillance. Clinical Infectious Diseases. 2009; 48 (2): 103–113.Arifeen В.E., Saha В.K., Rahman S. et al. Invasive Pneumococcal Disease among Children in Rural Bangladesh: Results from a Population Based Surveillance. Clinical Infectious Diseases. 2009; 48 (2): 103–113.Baggett В.C., Peruski В.F., Olsen В.J. et al. Incidence of Pneumococcal Bacteremia Requiring Hospitalization in Rural Thailand. Clinical Infectious Diseases. 2009; 48 (2): 65–74.Baggett В.C., Peruski В.F., Olsen В.J. et al. Incidence of Pneumococcal Bacteremia Requiring Hospitalization in Rural Thailand. Clinical Infectious Diseases. 2009; 48 (2): 65–74.Batuwanthudawe R., Karunarathne K., Dassanayake M. et al. Surveillance of Invasive Pneumococcal Disease in Colombo, Sri Lanka. Clinical Infectious Diseases. 2009; 48 (2): 136–140.Batuwanthudawe R., Karunarathne K., Dassanayake M. et al. Surveillance of Invasive Pneumococcal Disease in Colombo, Sri Lanka. Clinical Infectious Diseases. 2009; 48 (2): 136–140.Deloria Knoll M., Jennifer В.C., Muhib Farzana В.B. et al. Standardizing Surveillance of Pneumococcal Disease. Clinical Infectious Diseases. 2009; 48 (2): 37–48.Deloria Knoll M., Jennifer В.C., Muhib Farzana В.B. et al. Standardizing Surveillance of Pneumococcal Disease. Clinical Infectious Diseases. 2009; 48 (2): 37–48.Falade A.G., Lagunju В.A., Bakare В.A. et al. Invasive Pneumococcal Disease in Children Aged <5 Years Admitted to 3 Urban Hospitals in Ibadan, Nigeria. Clinical Infectious Diseases. 2009; 48 (2): 190–196.Falade A.G., Lagunju В.A., Bakare В.A. et al. Invasive Pneumococcal Disease in Children Aged <5 Years Admitted to 3 Urban Hospitals in Ibadan, Nigeria. Clinical Infectious Diseases. 2009; 48 (2): 190–196.Kisakye A., Makumbi I., Nansera D. et al. Surveillance for Streptococcus pneumoniae Meningitis in Children Aged <5 Years: Implications for Immunization in Uganda. Clinical Infectious Diseases. 2009; 48 (2): 153–161.Kisakye A., Makumbi I., Nansera D. et al. Surveillance for Streptococcus pneumoniae Meningitis in Children Aged <5 Years: Implications for Immunization in Uganda. Clinical Infectious Diseases. 2009; 48 (2): 153–161.Stephen В.P., Brooks В.A., Samir В.K. et al. Use of Multiple Surveillance Modalities to Assess the Epidemiology of Streptococcus pneumoniae Infection in Bangladesh. Clinical Infectious Diseases. 2009; 48 (2): 97–102.Stephen В.P., Brooks В.A., Samir В.K. et al. Use of Multiple Surveillance Modalities to Assess the Epidemiology of Streptococcus pneumoniae Infection in Bangladesh. Clinical Infectious Diseases. 2009; 48 (2): 97–102.Mendsaikhan J., Watt James В.P., Mansoor O. et al. Childhood Bacterial Meningitis in Ulaanbaatar, Mongolia 2002–2004. Clinical Infectious Diseases. 2009; 48 (2): 141–146.Mendsaikhan J., Watt James В.P., Mansoor O. et al. Childhood Bacterial Meningitis in Ulaanbaatar, Mongolia 2002–2004. Clinical Infectious Diseases. 2009; 48 (2): 141–146.Jennifer В.C, Samir В.K, Falade Adegoke В.G. et al. Enhanced Diagnosis of Pneumococcal Meningitis with Use of the Binax NOW Immunochromatographic Test of Streptococcus pneumoniae Antigen: A Multisite Study. Clinical Infectious Diseases. 2009; 48 (2): 49–56.Jennifer В.C, Samir В.K, Falade Adegoke В.G. et al. Enhanced Diagnosis of Pneumococcal Meningitis with Use of the Binax NOW Immunochromatographic Test of Streptococcus pneumoniae Antigen: A Multisite Study. Clinical Infectious Diseases. 2009; 48 (2): 49–56.Mudhune S., Wamae M. Report on Invasive Disease and Meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region. Clinical Infectious Diseases. 2009; 48 (2): 147–152.Mudhune S., Wamae M. Report on Invasive Disease and Meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region. Clinical Infectious Diseases. 2009; 48 (2): 147–152.Naheed A., Samir В.K, Breiman Robert В.F. Multihospital Surveillance of Pneumonia Burden among Children Aged <5 Years Hospitalized for Pneumonia in Bangladesh. Clinical Infectious Diseases. 2009; 48 (2): 82–89.Naheed A., Samir В.K, Breiman Robert В.F. Multihospital Surveillance of Pneumonia Burden among Children Aged <5 Years Hospitalized for Pneumonia in Bangladesh. Clinical Infectious Diseases. 2009; 48 (2): 82–89.Roca A., Bassat Q., Morais L. et al. Surveillance of Acute Bacterial Meningitis among Children Admitted to a District Hospital in Rural Mozambique. Clinical Infectious Diseases. 2009; 48 (2): 172–180.Roca A., Bassat Q., Morais L. et al. Surveillance of Acute Bacterial Meningitis among Children Admitted to a District Hospital in Rural Mozambique. Clinical Infectious Diseases. 2009; 48 (2): 172–180.Samir В.K., Khan Naila В.Z. et al. Neurodevelopmental Sequelae in Pneumococcal Meningitis Cases in Bangladesh. Clinical Infectious Diseases. 2009; 48 (2): 90–96.Samir В.K., Khan Naila В.Z. et al. Neurodevelopmental Sequelae in Pneumococcal Meningitis Cases in Bangladesh. Clinical Infectious Diseases. 2009; 48 (2): 90–96.Samir В.K., Naheed A., Arifeen Shams В.E. et al. Surveillance for Invasive Streptococcus pneumoniae Disease among Hospitalized Children in Bangladesh: Antimicrobial Susceptibility and Serotype Distribution. Clinical Infectious Diseases. 2009; 48 (2): 75–81.Samir В.K., Naheed A., Arifeen Shams В.E. et al. Surveillance for Invasive Streptococcus pneumoniae Disease among Hospitalized Children in Bangladesh: Antimicrobial Susceptibility and Serotype Distribution. Clinical Infectious Diseases. 2009; 48 (2): 75–81.Shah В.S, Deloria Knoll M., Sharma В.R. et al. Invasive Pneumococcal Disease in Kanti Children's Hospital, Nepal, as Observed by the South Asian Pneumococcal Alliance Network. Clinical Infectious Diseases. 2009; 48 (2): 123–128.Shah В.S, Deloria Knoll M., Sharma В.R. et al. Invasive Pneumococcal Disease in Kanti Children's Hospital, Nepal, as Observed by the South Asian Pneumococcal Alliance Network. Clinical Infectious Diseases. 2009; 48 (2): 123–128.Traore Y., Tameklo Tsidi В.A. et al. Incidence, Seasonality, Age Distribution, and Mortality of Pneumococcal Meningitis in Burkina Faso and Togo. Clinical Infectious Diseases. 2009; 48 (2): 181–189.Traore Y., Tameklo Tsidi В.A. et al. Incidence, Seasonality, Age Distribution, and Mortality of Pneumococcal Meningitis in Burkina Faso and Togo. Clinical Infectious Diseases. 2009; 48 (2): 181–189.Williams Eleri В.J., Thorson S., Maskey M. et al. Hospital Based Surveillance of Invasive Pneumococcal Disease among Young Children in Urban Nepal. Clinical Infectious Diseases. 2009; 48 (2): 114–122.Williams Eleri В.J., Thorson S., Maskey M. et al. Hospital Based Surveillance of Invasive Pneumococcal Disease among Young Children in Urban Nepal. Clinical Infectious Diseases. 2009; 48 (2): 114–122.Zaidi Anita В.M., Khan H., Lasi R. et al. Surveillance of Pneumococcal Meningitis among Children in Sindh, Southern Pakistan. Clinical Infectious Diseases. 2009; 48 (2): 129–135.Zaidi Anita В.M., Khan H., Lasi R. et al. Surveillance of Pneumococcal Meningitis among Children in Sindh, Southern Pakistan. Clinical Infectious Diseases. 2009; 48 (2): 129–135.Jefferson T., Ferroni E., Curtale F. et al. Streptococcus pneumoniae in Western Europe: serotype distribution and incidence in children less than 2 years old. Lancet. 2006; 6 (7): 405–410.Jefferson T., Ferroni E., Curtale F. et al. Streptococcus pneumoniae in Western Europe: serotype distribution and incidence in children less than 2 years old. Lancet. 2006; 6 (7): 405–410.Hsu H.E., Shutt K.A., Moore M.R. et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med. 2009; 360 (3): 244–256.Hsu H.E., Shutt K.A., Moore M.R. et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med. 2009; 360 (3): 244–256.Белошицкий Г.В., Королева И.С., Чистякова Г.Г. Эпидемиологические особенности менингитов, обусловленных S. pneumoniae. Эпидемиология и инфекционные болезни. 2005; 3: 28–30.Белошицкий Г.В., Королева И.С., Чистякова Г.Г. Эпидемиологические особенности менингитов, обусловленных S. pneumoniae. Эпидемиология и инфекционные болезни. 2005; 3: 28–30.Белошицкий Г.В., Королева И.С., Кошкина Н.И. Пневмококковые менингиты в Российской Федерации. Эпидемиология и вакцинопрофилактика. 2009; 2 (21): 6.Белошицкий Г.В., Королева И.С., Кошкина Н.И. Пневмококковые менингиты в Российской Федерации. Эпидемиология и вакцинопрофилактика. 2009; 2 (21): 6.Ruggeberg J.U., Ketteler K., MacKenzie C.R. et al. Blood culture sampling rates at a German pediatric university hospital and incidence of invasive pneumococcal disease. Infection. 2004; 32 (2): 78–81.Ruggeberg J.U., Ketteler K., MacKenzie C.R. et al. Blood culture sampling rates at a German pediatric university hospital and incidence of invasive pneumococcal disease. Infection. 2004; 32 (2): 78–81.Reinert R.R., Haupts S., Linden M. et al. Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003. Clin. Microbiol. Infect. 2005; 11 (12): 985–991.Reinert R.R., Haupts S., Linden M. et al. Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003. Clin. Microbiol. Infect. 2005; 11 (12): 985–991.Azzari C., Moriondo M., Indolfi G. et al. Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J. Med. Microbiol. 2008; 57 (10): 1205–1212.Azzari C., Moriondo M., Indolfi G. et al. Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J. Med. Microbiol. 2008; 57 (10): 1205–1212.Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine-United States, 1997–2006. MMWR.2009; 58 (1): 1–4.Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine-United States, 1997–2006. MMWR.2009; 58 (1): 1–4.Welte T., Kohnlein T. Global and local epidemiology of community acquired pneumonia: the experience of the CAPNETZ Network. Semin. Respir. Crit. Care Med. 2009; 30 (2): 127–135.Welte T., Kohnlein T. Global and local epidemiology of community acquired pneumonia: the experience of the CAPNETZ Network. Semin. Respir. Crit. Care Med. 2009; 30 (2): 127–135.Schnoor M., Hedicke J., Dalhoff K. et al. Approaches to estimate the population-based incidence of community acquired pneumonia. J. Infect. 2007; 55 (3): 233–239.Schnoor M., Hedicke J., Dalhoff K. et al. Approaches to estimate the population-based incidence of community acquired pneumonia. J. Infect. 2007; 55 (3): 233–239.Senstad A.C., Suren P., Brauteset L. et al. Community acquired pneumonia (CAP) in children in Oslo, Norway. Acta Paediatr. 2009; 98 (2): 332–336.Senstad A.C., Suren P., Brauteset L. et al. Community acquired pneumonia (CAP) in children in Oslo, Norway. Acta Paediatr. 2009; 98 (2): 332–336.Ogita J., Ishiwada N., Kurosaki T. et al. Incidence of community acquired pneumonia and pneumococcal pneumonia, among children in Chiba City, Japan. Kansenshogaku Zasshi. 2008; 82 (6): 624–627.Ogita J., Ishiwada N., Kurosaki T. et al. Incidence of community acquired pneumonia and pneumococcal pneumonia, among children in Chiba City, Japan. Kansenshogaku Zasshi. 2008; 82 (6): 624–627.O'Brien K.L., Wolfson L.J. Watt J.P. et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009; 374 (9693): 893–902.O'Brien K.L., Wolfson L.J. Watt J.P. et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009; 374 (9693): 893–902.Hausdorff W.P. Bryant J. Paradiso P.R. et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 2000; 30 (1): 100–121.Hausdorff W.P. Bryant J. Paradiso P.R. et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 2000; 30 (1): 100–121.Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998–2005. MMWR. 2008; 57 (6): 144–148.Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998–2005. MMWR. 2008; 57 (6): 144–148.Grijalva C.G., Nuorti J.P., Arbogast P.G. et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007; 369 (9568): 1179–1186.Grijalva C.G., Nuorti J.P., Arbogast P.G. et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007; 369 (9568): 1179–1186.Direct and indirect effects of routine vaccination of children with 7 valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease United States, 1998–2003. MMWR. 2005. Р.54, № 36. Р. 893–897.Direct and indirect effects of routine vaccination of children with 7 valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease United States, 1998–2003. MMWR. 2005. Р.54, № 36. Р. 893–897.Tyrrell G.J., Lovgren M., Chui N. et al. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre– and post– seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006. Vaccine. 2009; 27 (27): 3553–3560.Tyrrell G.J., Lovgren M., Chui N. et al. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre– and post– seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006. Vaccine. 2009; 27 (27): 3553–3560.De Carvalho Gomes H., Muscat M., Monnet D.L. et al. Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001–2007. Euro Surveill. 2009; 14 (12).De Carvalho Gomes H., Muscat M., Monnet D.L. et al. Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001–2007. Euro Surveill. 2009; 14 (12).URL: http://wwweurosurveillanceorg/ViewArticleaspx?ArticleId=18962URL: http://wwweurosurveillanceorg/ViewArticleaspx?ArticleId=18962Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. Weekly Epidemiological Record. 2007; 82 (12): 93–104.Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. Weekly Epidemiological Record. 2007; 82 (12): 93–104.Emergence of antimicrobial resistant serotype 19A Streptococcus pneumoniae Massachusetts, 2001–2006. MMWR. 2007; 56 (41): 1077–1080.Emergence of antimicrobial resistant serotype 19A Streptococcus pneumoniae Massachusetts, 2001–2006. MMWR. 2007; 56 (41): 1077–1080.Sa–Leao R., Nunes S., Brito-Avo A. et al. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day care centre attendees in Portugal, a country with widespread use of the seven valent pneumococcal conjugate vaccine. Clin. Microbiol. Infect. 2009.Sa–Leao R., Nunes S., Brito-Avo A. et al. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day care centre attendees in Portugal, a country with widespread use of the seven valent pneumococcal conjugate vaccine. Clin. Microbiol. Infect. 2009.Reinert R.R. The antimicrobial resistance profile of Streptococcus pneumoniae. Clinical Microbiology and Infection. 2009; 15 (3): 7–11.Reinert R.R. The antimicrobial resistance profile of Streptococcus pneumoniae. Clinical Microbiology and Infection. 2009; 15 (3): 7–11.

The authors declare that there are no conflicts of interest present.